OCEA logo

Ocean Biomedical (OCEA) Financials

Balance sheets

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202331 Dec 202230 Sept 202230 June 2022

Total Assets

$1.1 M(-38.8%)$1.9 M(-37.2%)$2.9 M(-46.5%)$5.5 M(+433.6%)$1.0 M(-99.1%)$110.9 M-$395.0 K

Current Assets

$1.0 M(-18.4%)$1.3 M(-29.0%)$1.8 M(-14.7%)$2.1 M(+104.6%)$1.0 M(+120.3%)$468.0 K-$395.0 K

Non Current Assets

$90.0 K(-84.3%)$574.0 K(-50.0%)$1.1 M(-66.2%)$3.4 M(+100.0%)$0.0(-100.0%)$110.4 M-$0.0

Total Liabilities

$99.2 M(+4.9%)$94.6 M(+20.1%)$78.7 M(-18.2%)$96.3 M(+26.2%)$76.3 M(+1053.0%)$6.6 M-$9.9 M

Current Liabilities

$33.6 M(+9.5%)$30.7 M(+2.1%)$30.1 M(+0.3%)$30.0 M(-2.7%)$30.9 M(+790.7%)$3.5 M-$9.9 M

Long Term Liabilities

$65.6 M(+2.7%)$63.9 M(+31.3%)$48.6 M(-26.6%)$66.3 M(+45.9%)$45.4 M(+1341.4%)$3.1 M-$0.0

Shareholders Equity

-$98.1 M(-5.8%)-$92.7 M(-22.4%)-$75.8 M(+16.5%)-$90.8 M(-20.7%)-$75.2 M(-172.1%)$104.3 M--$9.5 M

Book Value

-$98.1 M(-5.8%)-$92.7 M(-22.4%)-$75.8 M(+16.5%)-$90.8 M(-20.7%)-$75.2 M(-172.1%)$104.3 M--$9.5 M

Working Capital

-$32.6 M(-10.7%)-$29.5 M(-4.1%)-$28.3 M(-1.5%)-$27.9 M(+6.4%)-$29.8 M(-895.4%)-$3.0 M--$9.5 M

Cash And Cash Equivalents

$0.0(-100.0%)$4000.0(-79.0%)$19.0 K(+375.0%)$4000.0(-87.1%)$31.0 K(-90.6%)$328.3 K-$395.0 K

Accounts Payable

$862.0 K(-6.9%)$926.0 K(-6.6%)$991.0 K(+6.2%)$933.0 K(+718.4%)$114.0 K(-64.9%)$324.8 K-$528.0 K

Accounts Receivable

--------

Short Term Debt

$12.8 M(+16.9%)$11.0 M(+11.4%)$9.9 M(-18.7%)$12.1 M(+0.6%)$12.1 M(+460.5%)$2.1 M-$764.0 K

Long Term Debt

--------

Total Debt

$12.8 M(+16.9%)$11.0 M(+11.4%)$9.9 M(-18.7%)$12.1 M(+0.6%)$12.1 M(+460.5%)$2.1 M-$764.0 K

Debt To Equity

-0.1(-8.3%)-0.1(+7.7%)-0.1(0%)-0.1(+18.8%)-0.2(-900.0%)0.0--0.1

Current Ratio

0.0(-25.0%)0.0(-33.3%)0.1(-14.3%)0.1(+133.3%)0.0(-78.6%)0.1-0.0

Quick Ratio

--------

Inventory

--------

Retained Earnings

-$205.8 M(-2.8%)-$200.3 M(-9.4%)-$183.1 M(+6.6%)-$196.1 M(-9.4%)-$179.2 M(-6378.9%)-$2.8 M--$76.9 M

PB Ratio

--------

Income statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202331 Dec 202230 Sept 202230 June 2022

EPS

-$0.2(+68.3%)-$0.6(-231.3%)$0.5--$0.5--$0.2(+50.0%)-$0.4

TTM EPS

-$0.3(+48.5%)-$0.7(-1260.0%)-$0.1--$0.5--$0.5(-50.0%)-$0.4

Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

TTM Revenue

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Total Expenses

$768.0 K(+12.6%)$682.0 K(+14.6%)$595.0 K(+190.2%)-$660.0 K(-124.9%)$2.7 M(+120.9%)-$12.7 M(-500.3%)$3.2 M(-54.0%)$6.9 M

Operating Expenses

$768.0 K(+12.6%)$682.0 K(+14.6%)$595.0 K(+190.2%)-$660.0 K(-124.9%)$2.7 M(+120.9%)-$12.7 M(-500.3%)$3.2 M(-54.0%)$6.9 M

Cost Of Goods Sold

--------

TTM Cost Of Goods Sold

--------

Gross Profit

--------

TTM Gross Profit

--------

Gross Margin

--------

Operating Profit

-$768.0 K(-12.6%)-$682.0 K(-14.6%)-$595.0 K(-190.2%)$660.0 K(+124.9%)-$2.7 M(-120.9%)$12.7 M(+500.3%)-$3.2 M(+54.0%)-$6.9 M

TTM Operating Profit

-$1.4 M(+57.7%)-$3.3 M(-26.3%)-$2.6 M(-29.8%)-$2.0 M(-119.9%)$10.0 M(+282.2%)$2.6 M(+126.1%)-$10.1 M(-46.0%)-$6.9 M

Operating Margin

--------

Net Income

-$5.5 M(+67.9%)-$17.2 M(-232.6%)$13.0 M(+177.1%)-$16.9 M(-19.7%)-$14.1 M(-191.4%)$15.4 M(+520.3%)-$3.7 M(+50.0%)-$7.3 M

TTM Net Income

-$26.6 M(+24.3%)-$35.2 M(-96.0%)-$17.9 M(+42.0%)-$30.9 M(-2425.5%)$1.3 M(-69.9%)$4.4 M(+140.2%)-$11.0 M(-50.0%)-$7.3 M

Net Margin

--------

EBIT

-$5.1 M(+69.7%)-$16.7 M(-222.6%)$13.6 M(+183.4%)-$16.4 M(-18.6%)-$13.8 M(-190.2%)$15.3 M(+524.0%)-$3.6 M(+47.7%)-$6.9 M

TTM EBIT

-$24.5 M(+26.3%)-$33.2 M(-101.2%)-$16.5 M(+45.2%)-$30.1 M(-2112.3%)$1.5 M(-68.7%)$4.8 M(+145.5%)-$10.5 M(-52.3%)-$6.9 M

EBITDA

-$1.4 M(+53.5%)-$3.1 M(-376.2%)-$646.0 K(+26.1%)-$874.0 K(+68.4%)-$2.8 M(-118.1%)$15.3 M(+582.1%)-$3.2 M(+54.0%)-$6.9 M

TTM EBITDA

-$6.0 M(+18.1%)-$7.4 M(-71.8%)-$4.3 M(-17.7%)-$3.6 M(-129.1%)$12.5 M(+140.0%)$5.2 M(+151.8%)-$10.1 M(-46.0%)-$6.9 M

Selling, General & Administrative Expenses

$768.0 K(+12.6%)$682.0 K(+19.9%)$569.0 K(+188.5%)-$643.0 K(-127.4%)$2.4 M-$1.3 M(-64.5%)$3.7 M

TTM SG&A

$1.4 M(-53.5%)$3.0 M(+30.0%)$2.3 M(+33.3%)$1.7 M(-27.4%)$2.4 M-$5.0 M(+35.5%)$3.7 M

Depreciation And Amortization

--------

TTM D&A

--------

Interest Expense

$461.0 K(-10.5%)$515.0 K(-19.1%)$637.0 K(+27.4%)$500.0 K(+70.7%)$293.0 K(+333.8%)-$125.3 K(-305.4%)$61.0 K(+24.5%)$49.0 K

TTM Interest Expense

$2.1 M(+8.6%)$1.9 M(+36.0%)$1.4 M(+80.3%)$793.0 K(+372.9%)$167.7 K(+1195.4%)-$15.3 K(-113.9%)$110.0 K(+124.5%)$49.0 K

Income Tax

--------

TTM Income Tax

--------

PE Ratio

--------

PS Ratio

--------

Cashflow statements

30 Sept 202430 June 202431 Mar 202431 Dec 202330 Sept 202331 Dec 202230 Sept 202230 June 2022

Cash From Operations

-$885.0 K(-205.2%)-$290.0 K(+40.2%)-$485.0 K(+44.0%)-$866.0 K(+23.4%)-$1.1 M(-631.3%)$212.7 K(+148.2%)-$441.0 K(-190.1%)-$152.0 K

TTM CFO

-$2.5 M(+8.8%)-$2.8 M(-11.7%)-$2.5 M(-24.3%)-$2.0 M(-117.6%)-$917.3 K(-141.2%)-$380.3 K(+35.9%)-$593.0 K(-290.1%)-$152.0 K

Cash From Investing

--------

TTM CFI

--------

Cash From Financing

$896.0 K(+100.0%)$0.0(0%)$0.0(-100.0%)$839.0 K(+100.0%)$0.0(-100.0%)$1.1 M(+569.1%)$162.0 K(-36.5%)$255.0 K

TTM CFF

$1.7 M(+106.8%)$839.0 K(0%)$839.0 K(0%)$839.0 K(-22.6%)$1.1 M(-27.8%)$1.5 M(+259.9%)$417.0 K(+63.5%)$255.0 K

Free Cash Flow

-$885.0 K(-205.2%)-$290.0 K(+40.2%)-$485.0 K(+44.0%)-$866.0 K(+23.4%)-$1.1 M(-631.3%)$212.7 K(+148.1%)-$442.0 K(-190.8%)-$152.0 K

TTM FCF

-$2.5 M(+8.8%)-$2.8 M(-11.7%)-$2.5 M(-24.3%)-$2.0 M(-117.6%)-$917.3 K(-140.6%)-$381.3 K(+35.8%)-$594.0 K(-290.8%)-$152.0 K

CAPEX

--------

TTM CAPEX

--------

Dividends Paid

--------

TTM Dividends Paid

--------

TTM Dividend Per Share

--------

TTM Dividend Yield

--------

Payout Ratio

--------